Expert of the Directorate for Expert Evaluation of Bioequivalence Materials Khomenko R.M. took part as an expert on bioequivalence issues in the regular 113th assessment session of the Prequalification of Medicines Programme of the World Health Organization (WHO).
The assessment session took place from 13 to 17 January 2020 in Copenhagen, Denmark.
The main purpose of the session was to evaluate the dossier materials on medicinal products submitted by interested manufacturers wishing to take part in the procurement assessment procedure and to obtain priority medicines for the treatment of HIV/AIDS, malaria, and tuberculosis, antiviral products, specific anti-influenza products, zinc preparations for combating acute diarrhea, and medical products for the treatment of the reproductive system.
The participation of an expert from the Division for Expert Evaluation of Bioequivalence Materials in the team of experts of the medicinal product prequalification program demonstrates that the approaches to the expert evaluation of bioequivalence study materials are similar to those of international agencies, as well as the high qualification level of the Center's experts.
